Financial Payments From Drug Industry Associated With Increased Physician Prescribing

Elicit Deal Concept

Financial payments from drug companies to U.S. physicians were linked to increased prescribing of the paying company’s drug. This was found consistently across studies, with some suggesting a causal relationship.

A systematic review of published research found that financial payments from the drug industry to U.S. physicians was associated with increased prescribing of the paying drug company’s drug. The association was consistent across all studies and several studies presented evidence that the association was not correlation, but causation, meaning the industry gifts caused physicians to prescribe differently. The findings are published in Annals of Internal Medicine.

Financial payments from the drug industry to physicians is common and an issue of concern. Payments include both cash (typically for consulting services or invited lectures) and in-kind gifts, such as meals. From 2015 to 2017, 67% of all U.S. physicians received payments. This proportion exceeded 80% in some specialties (medical oncology, orthopedic surgery, urology, and others), and in many specialties the dollar value of personal payments has increased in recent years.

Researchers from Memorial Sloan Kettering Cancer Center reviewed 36 published studies comprising 101 analyses to evaluate whether receipt of payments from the drug industry is associated with physician prescribing practices. The researchers found that the literature was unanimous. Literally, every study found an association between gifts and prescribing and the association was present among all specialties and drug types, including cancer drugs and opioids. According to the researchers, these results suggest that personal payments from industry reduce physicians’ ability to make independent therapeutic decisions and that they may be harmful to patients. They recommend that the medical community change its historical opposition to reform and call for an end to such payments.

Reference: “Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? A Systematic Review” by Aaron P. Mitchell, MD, MPH, Niti U. Trivedi, MPH, Renee L. Gennarelli, MS, Susan Chimonas, PhD, Sara M. Tabatabai, BS, Johanna Goldberg, MSLIS, Luis A. Diaz Jr., MD and Deborah Korenstein, MD, 24 November 2020, Annals of Internal Medicine.
DOI: 10.7326/M20-5665

1 Comment on "Financial Payments From Drug Industry Associated With Increased Physician Prescribing"

  1. Sydney Ross Singer | June 17, 2024 at 6:21 am | Reply

    I left the field of medicine when I realized that it is not about health, but about profit. Medicine is a business, like all others. They sell drugs to treat symptoms. Prevention of disease goes against the medical money model, since they only get paid when you are sick. And since doctors have power over people, the field attracts psychopaths and sociopaths. The entire medical field is controlled by drug companies. I now am a medical anthropologist, studying the cultural causes of disease, and medicine is near the top of the list of problems. See my article Physicians, Power Seekers, and Perverts.

Leave a comment

Email address is optional. If provided, your email will not be published or shared.